| DNA lentivector for transduction information: |
GENTAUR suggests to use our ABM packaging mix LV003 of second generation virusses or the LV053, This DNA can alos be used for packaging into Lentiviral particles for high efficiency transduction and stably integrated expressions, Vectors with selection markers like kanamycin, our 3rd Generation Packaging mixture, pLenti lentiviral plasmids DNAs are stored in 10milliMolar Tris/HCI with 1mM EDTA at a pH of 8 at -25 C, puromycin or cumate are available, Lentiveral packaging plasmid DNA for non-viral plasmid transfection and direct use in plasmid expression |
| Properties: |
Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine, , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp |
| Gene target: |
CECR1 Lentiviral Vector (CMV) (pLenti-GIII-CMV-C-term-HA) |
| Short name: |
CECR1 Lentiviral Vector ( ) (CMV) (pLenti-GIII-CMV-C-term-HA) |
| Technique: |
Vectors |
| Species: |
Humans, Human |
| Alternative name: |
candidate 1 Lentiviral integrating Desoxyribonucleic acid sequence (H, sapiens) (cytomegalovirus) (pLenti-GIII-cytomegalovirus-c terminus-HA), catalase eye syndrome chromosome region |
| Alternative to gene target: |
CECR1 and IDBG-641275 and ENSBTAG00000017313 and 617805, CECR1 and IDBG-933 and ENSG00000093072 and 51816, Extracellular, candidate 1, proteoglycan binding, this GO :0004000 and adenosine deaminase activity and molecular function this GO :0005615 and extracellular space and cellular component this GO :0006154 and adenosine catabolic process and biological process this GO :0007275 and multicellular organismal development and biological process this GO :0008083 and growth factor activity and molecular function this GO :0008152 and metabolic process and biological process this GO :0008201 and heparin binding and molecular function this GO :0008270 and zinc ion binding and molecular function this GO :0019239 and deaminase activity and molecular function this GO :0031685 and adenosine receptor binding and molecular function this GO :0042803 and protein homodimerization activity and molecular function this GO :0043103 and hypoxanthine salvage and biological process this GO :0043394 and proteoglycan binding and molecular function this GO :0046103 and inosine biosynthetic process and biological process, this GO :0004000 : adenosine deaminase activity, this GO :0004000 : adenosine deaminase activity and also this GO :0008083 : growth factor activity and also this GO :0008201 : heparin binding and also this GO :0008270 : zinc ion binding and also this GO :0019239 : deaminase activity and also this GO :0031685 : adenosine receptor binding and also this GO :0042803 : protein homodimerization activity and also this GO :0043394 : proteoglycan binding, this GO :0008083 : growth factor activity, this GO :0008201 : heparin binding, this GO :0008270 : zinc ion binding, this GO :0019239 : deaminase activity, this GO :0031685 : adenosine receptor binding, this GO :0042803 : protein homodimerization activity, this GO :0043394 : proteoglycan binding, cat eye syndrome chromosome region |
| Identity: |
1839 |
| Gene: |
ADA2 |
More about : ADA2 |
| Long gene name: |
adenosine deaminase 2 |
| Synonyms gene: |
IDGFL CECR1 |
| Synonyms gene name: |
candidate 1 , cat eye syndrome chromosome region |
| Synonyms: |
ADGF |
| Locus: |
22q11, 1 |
| Discovery year: |
1999-12-09 |
| GenBank acession: |
AF190746 |
| Entrez gene record: |
51816 |
| Pubmed identfication: |
10756095 27663683 |
| Classification: |
Adenosine deaminase family |
| Havana BLAST/BLAT: |
OTTHUMG00000030726 |